Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

13
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

23
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
23
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

19
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
19
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

17
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
17
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

18
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
18
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

22
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
22

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multimodality staging of renal cell carcinoma-pearls & pitfalls.

Abdominal radiology (New York)·2026
Same author

Development and Use of a Population Pharmacokinetic Model for Characterizing the Pharmacokinetics of Vonoprazan in Pediatric Patients.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Marine plastic pollution undermines the livelihoods and income of fishing communities in Viet Nam.

Communications earth & environment·2026
Same author

PSMA PET: the answer to MRI-occult prostate cancer… or another mirage?

European radiology·2026
Same author

Quantitative imaging in cardiac transthyretin amyloidosis: rationale and design of the i-CARE study.

Cardiology journal·2026
Same author

Clinical significance of incidental, photopenic, high CT density renal lesions on [18F]FDG PET/CT.

The British journal of radiology·2026

Related Experiment Video

Updated: Aug 30, 2025

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model
06:03

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model

Published on: June 11, 2020

9.2K

[Myocarditis following mRNA vaccine].

Anna Formanek1, Thomas Wagner2, Stephan Newrkla3

  • 1Department of Paediatrics and Youth Medicine, Clinic Donaustadt, Langobardenstr. 122, 1220, Wien, Österreich. anna.formanek@gesundheitsverbund.at.

Wiener Medizinische Wochenschrift (1946)
|August 30, 2022
PubMed
Summary

A 15-year-old experienced myocarditis after the second dose of the BNT162b2 mRNA vaccine (Comirnaty®). Symptoms resolved quickly with rest and symptomatic treatment, indicating a mild course.

Keywords:
COVID19Chest painElevated level of TroponinMyocarditismRNA vaccine

More Related Videos

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
12:24

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

10.0K
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.8K

Related Experiment Videos

Last Updated: Aug 30, 2025

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model
06:03

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model

Published on: June 11, 2020

9.2K
Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
12:24

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

10.0K
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.8K

Area of Science:

  • Cardiology
  • Vaccinology
  • Pediatric Medicine

Context:

  • Myocarditis is a rare but serious condition affecting the heart muscle.
  • The BNT162b2 mRNA vaccine (Comirnaty®) is widely used for COVID-19 prevention.
  • Adolescents represent a key demographic for vaccination campaigns.

Purpose:

  • To report a case of myocarditis in an adolescent following BNT162b2 mRNA vaccination.
  • To describe the clinical presentation, diagnostic findings, and outcome of this case.

Summary:

  • A 15-year-old presented with chest pain four days post-BNT162b2 mRNA vaccination.
  • Elevated Troponin-I and cardiac MRI findings confirmed myocarditis.
  • The patient experienced a mild course with rapid symptom resolution after symptomatic therapy and bed rest.

Impact:

  • This case contributes to understanding the potential cardiac side effects of mRNA vaccines in adolescents.
  • Highlights the importance of considering vaccine-associated myocarditis in adolescents presenting with chest pain post-vaccination.
  • Emphasizes the generally favorable prognosis with prompt diagnosis and management.